PCOS Spotting: Causes and When to Worry

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

PCOS spotting happens when the uterine lining sheds irregularly because anovulation prevents progesterone production, leaving the endometrium estrogen-stimulated and unstable. Without ovulation, estrogen continues driving endometrial growth and the lining eventually sheds in fragments rather than in a single hormone-triggered event. Heavy bleeding with clots larger than a quarter may indicate endometrial hyperplasia and warrants prompt medical evaluation.

Read more →

Understand what your PCOS results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

You're spotting between periods and you're not sure if it's your PCOS or something else. Irregular bleeding is one of the most common PCOS symptoms, but it's also one of the most anxiety-inducing because the causes range from harmless hormonal fluctuations to something that warrants medical attention.

What happens in the uterus when you have PCOS

In a typical menstrual cycle, estrogen builds the uterine lining during the first half of the cycle, and progesterone stabilizes it after ovulation. When progesterone drops at the end of the cycle, the lining sheds in an organized way, producing a predictable period. With PCOS, this process breaks down. Without ovulation, the corpus luteum doesn't form, and progesterone production remains low or absent. Estrogen continues to stimulate the endometrium without the counterbalancing effect of progesterone, causing the lining to thicken unevenly.

Eventually, the lining becomes unstable and sheds in an irregular, unpredictable manner. The endometrium isn't shedding all at once in response to a hormonal signal; instead, it's breaking down in fragments as it outgrows its blood supply. This is what causes spotting between periods or prolonged episodes of light bleeding that don't resemble a normal menstrual flow.

How hormonal imbalance drives irregular bleeding

Estrogen dominance and endometrial overgrowth

Without progesterone to regulate endometrial growth, estrogen stimulates continuous thickening of the uterine lining. The result is spotting that occurs at unpredictable intervals, sometimes light and sometimes heavier, depending on how much tissue has accumulated.

Anovulatory cycles and breakthrough bleeding

Without ovulation, there's no progesterone surge to organize the shedding of the endometrium. Instead, the lining continues to thicken until it becomes mechanically unstable, leading to breakthrough bleeding. This type of bleeding can be light and intermittent, or it can present as a prolonged, irregular flow that doesn't follow a predictable cycle.

Insulin resistance and androgen excess

Insulin resistance, present in many women with PCOS, amplifies hormonal dysfunction. Elevated insulin levels increase ovarian androgen production, which further disrupts normal follicle development and ovulation. High androgens also interfere with the hypothalamic-pituitary-ovarian axis, perpetuating anovulation and irregular bleeding patterns.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Why some women experience heavy bleeding and clots

While some women with PCOS experience light spotting, others have the opposite problem: heavy periods with large blood clots. This happens when the endometrium has been building for an extended period without shedding. When it finally does shed, the volume of tissue is substantial, and the bleeding can be rapid and heavy. In a normal period, enzymes break down clotting factors to keep menstrual blood liquid. But when the flow is heavy and fast, clots form before these enzymes can act. Larger clots, especially those bigger than a quarter, can indicate significant endometrial buildup and warrant medical evaluation.

Heavy bleeding episodes in PCOS are often preceded by months of amenorrhea or light spotting. The longer the interval between periods, the thicker the lining becomes, and the heavier the eventual bleed.

What drives spotting patterns in PCOS

  • Frequency and duration of anovulation determine how regular bleeding patterns are, with occasional ovulation producing intermittent spotting and rare ovulation causing prolonged amenorrhea followed by heavy bleeding.
  • Degree of insulin resistance worsens hormonal imbalance by increasing androgen production and disrupting ovulation, leading to more severe menstrual irregularities.
  • Body weight and adipose tissue influence circulating estrogen levels through androgen conversion, which can exacerbate endometrial overgrowth.
  • Stress and cortisol dysregulation suppress the hypothalamic-pituitary-ovarian axis, worsening anovulation and triggering spotting or further delaying periods.

Why bleeding patterns vary between women with PCOS

Not all women with PCOS experience the same bleeding patterns. Genetic differences influence how sensitive the endometrium is to estrogen and how efficiently the body metabolizes hormones. Some women have more robust progesterone production even without full ovulation, which can reduce the severity of spotting. Others have more pronounced insulin resistance or higher androgen levels, which worsen anovulation and bleeding irregularities.

Prior use of hormonal contraceptives can also affect bleeding patterns. Women who have been on birth control pills may experience more regular cycles initially after stopping, but anovulation often returns over time if PCOS is not managed. Conversely, women who have never used hormonal contraception may have more erratic patterns from the outset.

Thyroid function plays a role as well. Hypothyroidism, which is more common in women with PCOS, can worsen menstrual irregularities and contribute to heavier bleeding. Addressing thyroid dysfunction can sometimes improve cycle regularity even without directly treating PCOS.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

When spotting signals something more serious

Persistent spotting or prolonged periods of amenorrhea followed by heavy bleeding can indicate endometrial hyperplasia, a condition where the uterine lining becomes abnormally thick. Left untreated, endometrial hyperplasia can progress to atypical hyperplasia, which carries a higher risk of endometrial cancer. Women with PCOS have a 2.7-fold increased risk of endometrial cancer compared to the general population.

Heavy bleeding that soaks through a pad or tampon every hour for several hours, or bleeding that lasts longer than seven days, should be evaluated. This level of blood loss can lead to anemia and may require medical intervention to stop the bleeding and assess the endometrium.

Postmenopausal bleeding or bleeding after a prolonged period of amenorrhea (more than six months) should always be investigated. While anovulation is common in PCOS, extended periods without shedding the endometrium increase the risk of hyperplasia and require assessment with imaging or biopsy.

If spotting is accompanied by pelvic pain, fever, or unusual discharge, it may indicate an infection or other structural issue unrelated to PCOS. These symptoms require prompt medical attention.

Using biomarkers to understand your bleeding patterns

Tracking hormonal and metabolic markers over time provides insight into what's driving your bleeding patterns and whether interventions are working. Key biomarkers include estradiol, progesterone, testosterone, luteinizing hormone, and follicle-stimulating hormone.

Insulin and glucose markers, including fasting insulin, hemoglobin A1c, and fasting glucose, help assess insulin resistance, which directly impacts ovulation and bleeding regularity. Improving insulin sensitivity through diet, exercise, or medication like metformin can restore more regular cycles in some women.

Thyroid markers, including TSH, free T4, and thyroid antibodies, should be checked if bleeding patterns worsen or if other symptoms of hypothyroidism are present. Correcting thyroid dysfunction can improve menstrual regularity and reduce heavy bleeding.

Inflammatory markers like high-sensitivity C-reactive protein can reflect underlying metabolic dysfunction that contributes to hormonal imbalance. Chronic inflammation worsens insulin resistance and can perpetuate anovulation.

Tracking these markers over time, rather than relying on a single snapshot, reveals trends and helps distinguish between normal fluctuations and patterns that require intervention.

How Superpower helps you monitor PCOS symptoms

If you're managing PCOS and trying to understand your bleeding patterns, Superpower's baseline blood panel measures over 100 biomarkers, including the hormonal and metabolic markers that drive cycle irregularity. Tracking these over time shows whether your interventions are working and helps you catch changes before they become problems. PCOS isn't static, and neither should your data be.

Frequently Asked Questions

References

  1. Dumesic DA, Lobo RA (2013). Cancer risk and PCOS. *Steroids*, *78*(8), 782-5. https://doi.org/10.1016/j.steroids.2013.04.004
  2. Singh G, Cue L, Puckett Y (2024). *Endometrial hyperplasia*. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK560693/
  3. Hickey M, Karthigasu K, Agarwal S (2009). Abnormal uterine bleeding: a focus on polycystic ovary syndrome. *Women's Health (London, England)*, *5*(3), 313-324. https://doi.org/10.2217/whe.09.20
  4. Barry JA, Azizia MM, Hardiman PJ (2014). Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. *Human Reproduction Update*, *20*(5), 748-758. https://doi.org/10.1093/humupd/dmu012
  5. Charalampakis V, Tahrani AA, Helmy A, Gupta JK, Singhal R (2016). Polycystic ovary syndrome and endometrial hyperplasia: an overview of the role of bariatric surgery in female fertility. *European Journal of Obstetrics, Gynecology, and Reproductive Biology*, *207*, 220-226. https://doi.org/10.1016/j.ejogrb.2016.10.001

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey